WILLIAMS DOUGLAS E

CIK 000118484714 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001184847

Recent Transactions

50 trades

Award
Climb Bio, Inc.$CLYM
Stock Option (Right to Buy)
2025-06-04+40,000→ 40,000 total
Award
Climb Bio, Inc.$CLYM
Stock Option (Right to Buy)
2025-03-31+78,873→ 78,873 total
Award
Camp4 Therapeutics Corp$CAMP
Stock Option (Right to Buy)
2025-03-17+17,787→ 17,787 total
Award
Climb Bio, Inc.$CLYM
Stock Option (Right to Buy)
2024-11-11+20,000→ 20,000 total
Award
Climb Bio, Inc.$CLYM
Stock Option (Right to Buy)
2024-11-11+6,291→ 6,291 total
Award
Sana Biotechnology, Inc.$SANA
Restricted Stock Units
2024-03-07+67,083→ 67,083 total
Award
Sana Biotechnology, Inc.$SANA
Stock Option (Right to Buy)
2024-03-07+301,875→ 301,875 total
Award
Sana Biotechnology, Inc.$SANA
Restricted Stock Units
2023-11-02+10,000→ 10,000 total
Award
Sana Biotechnology, Inc.$SANA
Stock Option (Right to Buy)
2023-04-10+1,100,000→ 1,100,000 total
Sale
Codiak BioSciences, Inc.
Common Stock
2023-03-28$0.18/sh−41,667→ 7,655 total
Sale
Codiak BioSciences, Inc.
Common Stock
2023-02-17$0.59/sh−7,681→ 49,322 total
Exercise/Conversion
Codiak BioSciences, Inc.
Common Stock
2023-02-16+22,969→ 57,003 total
Exercise/Conversion
Codiak BioSciences, Inc.
Restricted Stock Units
2023-02-16−22,969→ 45,937 total
Award
Codiak BioSciences, Inc.
Stock Option (Right to Buy)
2023-01-24+465,000→ 465,000 total
Sale
Codiak BioSciences, Inc.
Common Stock
2023-01-20$0.57/sh−5,075→ 18,177 total
Exercise/Conversion
Codiak BioSciences, Inc.
Common Stock
2023-01-19+13,667→ 23,252 total
Exercise/Conversion
Codiak BioSciences, Inc.
Restricted Stock Units
2023-01-19−13,667→ 27,333 total
Sale
Codiak BioSciences, Inc.
Common Stock
2022-08-17$2.21/sh−7,112→ 34,034 total
Exercise/Conversion
Codiak BioSciences, Inc.
Common Stock
2022-08-16+22,969→ 41,146 total
Exercise/Conversion
Codiak BioSciences, Inc.
Restricted Stock Units
2022-08-16−22,969→ 68,906 total
Award
Codiak BioSciences, Inc.
Restricted Stock Units
2022-02-16+91,875→ 91,875 total
Award
Codiak BioSciences, Inc.
Stock Option (Right to Buy)
2022-02-16+61,250→ 61,250 total
Award
Codiak BioSciences, Inc.
Stock Option (Right to Buy)
2022-01-19+200,000→ 200,000 total
Award
Codiak BioSciences, Inc.
Restricted Stock Units
2022-01-19+41,000→ 41,000 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2021-05-17+1,750→ 1,750 total
Award
Codiak BioSciences, Inc.
Stock Option (Right to Buy)
2021-01-22−175,000→ 175,000 total
Conversion
Codiak BioSciences, Inc.
Series C Preferred Stock
2020-10-16−66,004→ 0 total
Conversion
Codiak BioSciences, Inc.
Common Stock
2020-10-16+9,585→ 9,585 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2020-06-05+13,250→ 13,250 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (right to buy)
2019-11-13+7,437→ 7,437 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2019-06-10+5,813→ 5,813 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2019-06-07+5,813→ 5,813 total
Disposition to Issuer
IRONWOOD PHARMACEUTICALS INC$IRWD
Class A Common Stock
2019-04-01−4,056→ 87,800 total
Purchase
Ovid Therapeutics Inc.$OVID
Common Stock
2018-08-14$6.49/sh+5,000→ 5,000 total
Award
Ovid Therapeutics Inc.$OVID
Stock Option (Right to Buy)
2018-06-07+5,813→ 5,813 total
Award
IRONWOOD PHARMACEUTICALS INC$IRWD
Class A Common Stock
2018-05-31+16,223→ 91,856 total
Award
IRONWOOD PHARMACEUTICALS INC$IRWD
Class A Common Stock
2017-05-31+15,625→ 75,633 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2016-06-02+36,620→ 36,620 total
Award
IRONWOOD PHARMACEUTICALS INC$IRWD
Class A Common Stock
2016-06-01+23,674→ 60,008 total
Sale
BIOGEN INC.$BIIB
Common Stock
2015-06-19$410.00/sh−3,841→ 11,817 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2015-06-10+17,500→ 17,500 total
Award
IRONWOOD PHARMACEUTICALS INC$IRWD
Class A Common Stock
2015-06-03+16,556→ 36,334 total
Award
BIOGEN INC.$BIIB
Restricted Stock Unit
2015-02-23+8,300→ 8,300 total
Tax Payment
BIOGEN INC.$BIIB
Common Stock
2015-02-12$392.11/sh−767→ 15,658 total
Exercise/Conversion
BIOGEN INC.$BIIB
Restricted Stock Unit
2015-02-12−3,573→ 7,149 total
Other
BIOGEN INC.$BIIB
Restricted Stock Unit
2015-02-12−1,041→ 5,342 total
Exercise/Conversion
BIOGEN INC.$BIIB
Common Stock
2015-02-12+3,573→ 16,481 total
Exercise/Conversion
BIOGEN INC.$BIIB
Restricted Stock Unit
2015-02-12−1,627→ 6,383 total
Tax Payment
BIOGEN INC.$BIIB
Common Stock
2015-02-12$392.11/sh−1,683→ 14,798 total
Exercise/Conversion
BIOGEN INC.$BIIB
Common Stock
2015-02-12+1,627→ 16,425 total

Companies

Recent Filings

Address

2601 FOURTH AVENUE SUITE 500

SEATTLE, WA, 98121

View on SEC.gov